Traws Pharma, Inc. — Director's Dealing 2022

Jan 10, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2022-01-07

Reporting Person: OLER ABRAHAM N. (SVP Corp Dev & Gen Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-01-07	Common Stock	P	1500	$2.39	Acquired	20014	Direct

Footnotes

F1: The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: Includes 10,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee.